Metrics as of 10/17/2026, 04:16 AM (Berlin time), refresh in progress.
Organigram Global Stock
Organigram Global Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- CEO
- James Yamanaka
- Employees
- 1,139
- Market cap
- $131 M
- IPO
- 21/05/2019
Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and…
Organigram Global stock: price history
1D
-0.5%
1W
-3.4%
1M
-12.6%
6M
-36.5%
YTD
-44.8%
1Y
-51.0%
2Y
-46.7%
5Y
-89.7%
10Y
–
Next earnings date
Next earnings date
15/12/2026 (in 59 days)
Volatility around earnings
~31% stronger price swings than usual
Ask the agents about Organigram Global
Analyst assessment of Organigram Global
0
STRONG BUY
2
BUY
2
HOLD
1
SELL
0
STRONG SELL
5
TOTAL · Buy
As of: 17/07/2023
Organigram Global stock metrics
P/E
2.05
P/B
0.37
EV/EBITDA
-7.36
RETURN ON EQUITY
19.0%
NET MARGIN
99.8%
DEBT/EQUITY
0.04
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
68.8%
FLOAT SHARES
97,033,843
AVG. DAILY VOLUME (30D)
497,265
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Organigram Global stock
What does Organigram Global do?
Organigram Global Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is James Yamanaka, the company employs around 1,139 people.
The IPO was on 21/05/2019; the stock trades on NASDAQ under the ticker OGI.
What do analysts say about Organigram Global stock?
5 analysts rate the stock, the consensus is Buy (as of 17/07/2023).
This is an external assessment, not a statement by Market Jury.
When does Organigram Global report next?
The next earnings date is 15/12/2026.
Around past earnings, price swings were roughly 31% stronger than usual.
Does Organigram Global pay a dividend?
No, Organigram Global currently does not pay a dividend.
Which stocks are comparable to Organigram Global?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Organigram Global stock analyzed?
Clicking "Analyze stock" lets five strategies assess Organigram Global against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.